[1] |
Kaplan D H, Igyarto B Z, Gaspari A A. Early immune events in the induction of allergic contact dermatitis[J]. Nature Reviews Immunology, 2012, 12 (2) : 114-124.
doi: 10.1038/nri3150
pmid: 22240625
|
[2] |
Thyssen J P, Linneberg A, Menné T, et al. The epidemiology of contact allergy in the general population-prevalence and main findings[J]. Contact Dermatitis, 2007, 57 (5) : 287-299.
doi: 10.1111/cod.2007.57.issue-5
|
[3] |
Urbisch D, Becker M, Honarvar N, et al. Assessment of pre- and pro-haptens using nonanimal test methods for skin sensitization[J]. Chemical Research Toxicology, 2016, 29:901-913.
doi: 10.1021/acs.chemrestox.6b00055
|
[4] |
Eijl S V, Zhu Z, Cupitt J, et al. Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling[J]. PLoS One, 2012, 7 (7) : e41721.
doi: 10.1371/journal.pone.0041721
|
[5] |
Jeong J O, Eun S P, Seong S K, et al. Local lymph node assay: 5-bromo-d-deoxyuridine-ELISA method for comparative study in assessing chemical potencies and skin sensitization in BALB/c and CBA/J strains[J]. Toxicology Reports, 2022, 9: 499-504.
doi: 10.1016/j.toxrep.2022.03.017
pmid: 35345861
|
[6] |
Mika I, Yusuke Y, Masaharu F, et al. Applicability of ADRA (4 mM) for the prediction of skin sensitization by combining multiple alternative methods to evaluate key events[J]. Journal of Applied Toxicology, 2022, 42 (7).
|
[7] |
OECD. In chemico skin sensitisation: assays addressing the adverse outcome pathway key event on covalent binding to proteins:test guideline No. 442C [S]. Paris, France: OECD, 2021.
|
[8] |
OECD. In vitro skin sensitisation assays addressing the AOP key event on keratinocyte activation:test guideline No. 442D [S]. Paris, France: OECD, 2018.
|
[9] |
OECD. In vitro skin sensitisation assays addressing the key event on activation of dendritic cells on the adverse outcome pathway for skin sensitisation:test guideline No. 442E [S]. Paris, France: OECD, 2018.
|
[10] |
Food and Drug Administration of the People’s Republic of China cosmetic standards Expert Committee. Safety and Technical Standards for Cosmetics[S]. Beijng: People’s Medical Publishing House, 2017.
|
[11] |
Wang K, Liu X, Xv H R, et al. Research progress in pharmacology, pharmacokinetics and toxicity of natural furanocoumarins[J]. Chinese Journal of Pharmacology and Toxicology, 2021, 35 (4) : 312-320.
doi: 10.3867/j.issn.1000-3002.2021.04.010
|
[12] |
Reynolds G, Reynolds J, Gilmour N, et al. A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products[J]. Regulatory Toxicology and Pharmacology, 2021, 127.
|
[13] |
Fagen Z, Tim E, Joanna K, et al. A highly sensitive and selective high pressure liquid chromatography with tandem mass spectrometry (HPLC/MS-MS) method for the direct peptide reactivity assay (DPRA)[J]. Journal of Pharmacological and Toxicological Methods, 2018, 94:1-15.
doi: S1056-8719(18)30649-X
pmid: 30099091
|
[14] |
Sayaka, Wanibuchi, Yusuke, et al. The amino acid derivative reactivity assay with fluorescence detection and its application to multi-constituent substances[J]. The Journal of Toxicological Sciences, 2019, 44 (12) : 821-832.
doi: 10.2131/jts.44.821
|